Keywords: complications of catheter ablation; direct oral anticoagulant; pulmonary vein isolation; AF; atrial fibrillation; CI; confidence interval; CRNMB; clinically relevant nonmajor bleeding; DOACs; direct oral anticoagulants; MB; major bleeding; NOS; Newcastle-
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Apixaban; Dabigatran; DOACs; Edoxaban; Measurement; Reversal; Rivaroxaban;
Keywords: AF; atrial fibrillation; BWH; Brigham and Women's Hospital; DOACs; direct oral anticoagulants; HULP; Hospital Universitario La Paz; INR; international normalized ratio; IPAH; idiopathic pulmonary arterial hypertension; IQR; interquartilic range; mPAP; mea
Keywords: Blood coagulation; Tissue factor; Thrombin; Platelets; Protease-activated receptors; Metastasis; AT; antithrombin; BMI; body mass index; CA-125; cancer antigen 125; CCC; clear cell carcinoma; CD; cluster of differentiation; CG; control group; DVT; deep ve
Keywords: ACCP; American College of Chest Physicians; DOACS; Direct oral anticoagulants; HIT; heparin induced thrombocytopenia; LMWH; low molecular weight heparin; UFH; unfractionated heparin; VKA; vitamin K antagonists; Anticoagulation; Children; Pediatric; Hepari
Keywords: Direct oral anticoagulants; DOACs; Nonvalvular atrial fibrillation; Postmarketing studies; Safety;
Keywords: Atrial fibrillation; Non-end-stage chronic kidney disease; Major bleeding; Warfarin; Direct oral anticoagulants; Atrial fibrillation; AF; Direct oral anticoagulants; DOACs; Chronic kidney disease; CKD; Non-end-stage chronic kidney disease; NECKD; Vitamin
Keywords: Direct oral anticoagulants; DOACs; activated partial thromboplastin time; prothrombin time; patient samples; calibrators;
Keywords: AF; atrial fibrillation; INR; international normalized ratio; factor Xa; activated factor X; DOACs; direct-acting oral anticoagulants; RCTs; randomized controlled trials; RE-LY; Dabigatran Randomized Evaluation of Long-Term Anticoagulant Therapy; ROCKET-A
Sex Implications in the Response to Anticoagulant Therapy in Atrial Fibrillationâ
Keywords: anticoagulants; atrial fibrillation; DOACs; men; sex; women;
Measurement of apixaban, dabigatran, edoxaban and rivaroxaban in human plasma using automated online solid-phase extraction combined with ultra-performance liquid chromatography-tandem mass spectrometry and its comparison with coagulation assays
Keywords: aPTT; activated partial thromboplastin time; BEH; bridged ethyl hybrid; CV; coefficient of variation; DOACs; direct oral anticoagulants; DTI; direct thrombin inhibitor(s); IS; internal standard; MRM; multiple reaction monitoring mode; MS/MS; tandem mass s
Determination of edoxaban equivalent concentrations in human plasma by an automated anti-factor Xa chromogenic assay
Keywords: AE; Adverse events; aPTT; activated partial thromboplastin time; ANOVA; Analysis of variance; CI; Confidence interval; DOACs; Direct oral anticoagulants; FDA; Food and Drug Administration; FXa; Factor Xa; GLSM; Geometric least squares means; LC/MS/MS; Liq
International Normalized Ratio Is Significantly Elevated With Rivaroxaban and Apixaban Drug Therapies: A Retrospective Study
Keywords: anticoagulants; apixaban; direct anti-factor Xa inhibitors; DOACs; INR elevation; rivaroxaban;
The Direct Factor Xa Inhibitor Rivaroxaban Passes Into Human Breast Milk
Keywords: breastfeeding; lactation; liquid chromatography tandem-mass spectrometry; pulmonary embolism; rivaroxaban; DOACs; direct-acting oral anticoagulants;
Bleeding in patients with atrial fibrillation treated with dabigatran, rivaroxaban or warfarin: A retrospective population-based cohort study
Keywords: Real-world; DOACs; Bleeding risk